OUR PRODUCTS
Our Partners
We work hand-in-hand with carefully chosen partners to commercialize our products and to ensure supply and access for the people who need them.
Global Partnerships and Direct Commercialization
We have an extensive sales and marketing network through our global commercialization partnerships with Biogen, Organon, Sandoz, Teva, and Harrow. In Korea, we have partnerships with Boryung Pharmaceutical, Samil Pharmaceutical, and Hanmi Pharmaceutical for commercialization of oncology, ophthalmology, and endocrinology biosimilars, respectively. We also have established our own direct commercialization network for several countries; in Europe, we launched hematology/nephrology/neurology, ophthalmology, endocrinology products. In Korea, we directly commercialize immunology and hematology/nephrology/neurology products.
Reliable Supply Chain Network
Our Products are manufactured to the highest quality standards by collaborating with world- class manufacturing part-ners across Europe, North America and Asia. We have delivered 78 million units of our products to patients across more than 40 countries in a timely manner, without any major supply/safety issues.
'We have
- Strategic partnerships with multiple
industry leading manufacturers - Stringent quality control
in manufacturing - Robust supply routes throughout
EU, US and APAC area
